Feb 22, 2018 12:01 pm UTC| Business
Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis Diagnosis is one of the most important issues affecting health, longevity and well-being for rare disease...
PROVECTUS BIOPHARMACEUTICALS PROVIDES UPDATE ON GI CANCER PROGRAM FOR INVESTIGATIONAL DRUG PV-10
Feb 22, 2018 12:01 pm UTC| Business
Current Phase 1 basket study continues to enroll and treat patients for HCC and liver cancer metastases (colorectal, lung, pancreatic, melanoma, ovarian, and breast); updated data presentation planned for 2018 First...
Brazil Minerals, Inc. Provides Updates on Its New Active Gold Production Area
Feb 22, 2018 12:01 pm UTC| Business
PASADENA, Calif., Feb. 22, 2018 -- via OTC PR WIRE--Brazil Minerals, Inc. (USOTC:BMIX) (the "Company" or "Brazil Minerals") announced today that a new field in one of its properties in the Jequitinhonha River valley in...
Bev Industry News This Week Covers the High-Growth Functional Beverage Sector
Feb 22, 2018 12:00 pm UTC| Business
WASHOUGAL, WA, Feb. 22, 2018 -- This week in Bev Industry News we report on the high-growth functional beverage sector and highlight publicly-traded Glucose Health -- ticker (OTC PINK: GLUC) -- which makes...
LKQ Corporation Announces Results for Fourth Quarter and Full Year 2017
Feb 22, 2018 12:00 pm UTC| Business
Annual revenue growth of 13.4% to $9.74 billion; fourth quarter growth of 14.9%Annual organic revenue growth for parts and services of 4.1%; fourth quarter organic growth of 4.8%Tax reform net benefit of $22 million...
Feb 22, 2018 12:00 pm UTC| Business
XERMELO® (telotristat ethyl) U.S. Net Sales Since March 2017 Launch Reach $15.1 Million Regulatory Filings for Sotagliflozin in Patients with Type 1 Diabetes Expected in First Quarter of 2018 THE WOODLANDS, Texas, Feb. ...
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
Feb 22, 2018 12:00 pm UTC| Business
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of careREMEDY trial lead by prominent neurologist Dr. Bruce Campbell, its Principal...